Startups
ENYO Pharma

ENYO Pharma

https://enyopharma.com

Vonafexor drug maker for the treatment of Alport syndrome.

Summary

Seedtable Score
  • 42
Locations
Company Size
  • 1 to 10 employees
Last Stage Round
  • Series C
Industry

Insights

This section hypothesizes why ENYO Pharma can be a $10 billion dollar company in 10 years, in 10 lines or less.


ENYO Pharma has a promising pipeline of innovative biotech solutions targeting viral infections and autoimmune diseases, with strong scientific expertise and strategic partnerships.

Total funding Amount

$120M

Fundraising History

  • Jan 03 '24 Series C
    $43M
  • Jun 04 '18 Series B
    $44M
  • Jan 03 '16 Series A
    $24M

Investors

  • Bpifrance
    Series B
  • OrbiMed
    Series B
  • Andera Partners
    Series B
  • Morningside Venture Investments
    Series C
  • Sofinnova Partners
    Series A